Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: Henry Niman who wrote (29107)	8/2/1999 2:43:00 AM
From: Mike Heimbuch	Read Replies (1) \| Respond to of 32384

Henry: Re - DIAB II from Biotech Holdings A few years back I wrote you regarding this type II diabetes drug from Biotech Holdings out of Vancouver - Have you heard anything about them ever? They have signed distribution agreements with 4 S. American country pharma reps and finished another trial in Brazil. Deutsch Morgan and Grenfell gave them a good looking over. Still nothing definitive from them about the mechanism - but the stock is starting to trade quite heavily with little or no promotion. If you ever get the inclination to take another look I would be interested Mike up North